EMBC - Embecta Corp.
NEXT EARNINGS:
May 8, 2026
EPS Est: $0.42
|
Rev Est: $235.7M
Price:
--
--
|
CONSENSUS:
Sell
DETAILS
|
PRICE TARGET:
$22.50
DETAILS
HIGH:
$25.00
LOW:
$20.00
MEDIAN:
$22.50
CONSENSUS:
$22.50
UPSIDE:
118.87%
Market Cap:
608.78M
Volume:
880,259
Avg Volume:
792,023
52 Week Range:
9.2-15.55
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.06
Last Dividend:
$0.60
Exchange:
NASDAQ
Country:
US
Employees:
2,000
IPO Date:
2022-03-22
EPS (TTM):
1.64
P/E Ratio:
8.62
Revenue (TTM):
1.08B
Total Assets:
1.09B
Total Debt:
1.43B
Cash & Equiv:
225.50M
Rev Growth (5Y):
-0.1%
EPS Growth (5Y):
-26.2%
FCF Growth (5Y):
-16.8%
ROCE:
29.4%
Debt/Equity:
-2.20
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $0.71 | $0.67 | +6.0% | $261.2M | $235.7M | +10.8% |
| 2025-11-25 | $0.50 | $0.70 | -28.6% | $264.0M | $258.2M | +2.2% |
| 2025-08-08 | $1.12 | $0.46 | +146.2% | $295.5M | $265.7M | +11.2% |
| 2025-05-09 | $0.70 | $0.66 | +6.1% | $259.0M | $278.8M | -7.1% |
| 2025-02-06 | $0.65 | $0.45 | +44.4% | $261.9M | $264.4M | -0.9% |
| 2024-11-26 | $0.45 | $0.36 | +25.0% | $286.1M | $277.0M | +3.3% |
| 2024-08-09 | $0.74 | $0.48 | +54.2% | $272.5M | $277.0M | -1.6% |
| 2024-05-09 | $0.67 | $0.43 | +55.8% | $287.2M | $264.7M | +8.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.08B | 1.12B | 1.12B | 1.13B | 1.17B | 1.09B | 1.11B |
| Net Income | 95.40M | 78.30M | 70.40M | 223.60M | 414.80M | 427.60M | 432.00M |
| EPS | 1.64 | 1.36 | 1.23 | 3.92 | 7.31 | 7.50 | 7.58 |
| Total Assets | 1.09B | 1.29B | 1.21B | 1.09B | 788.00M | 738.00M | 745.00M |
| Total Debt | 1.43B | 1.61B | 1.66B | 1.64B | 4.00M | 5.00M | 0 |
| Cash & Equivalents | 225.50M | 267.50M | 326.50M | 330.90M | 0 | 0 | 0 |
| Operating Cash Flow | 191.70M | 35.70M | 67.70M | 412.20M | 456.00M | 498.50M | 505.00M |
| Free Cash Flow | 182.40M | 19.90M | 41.20M | 388.20M | 417.00M | 456.60M | 436.00M |
| FCF per Share | 3.13 | 0.34 | 0.72 | 6.80 | 7.34 | 8.01 | 7.65 |
| Book Value | (650.60M) | (738.30M) | (821.70M) | (891.40M) | 594.00M | 572.00M | 577.00M |
| Cash & ST Investments | 225.50M | 267.50M | 326.50M | 330.90M | 0 | 0 | 0 |
| ROC Equity | N/A | N/A | N/A | N/A | 0.70 | 0.75 | 0.75 |